Cancer scientists in London believe they have found a way to find the 'achilles heel' of tumours, in what is being described as a potential major breakthrough.
A team from University College says that by analysing patients' DNA, bespoke treatment can be chosen for cancer sufferers, thus steering the immune system to kill off tumours.
Some experts warn the process could be expensive and complicated.
Others say it could help immunotherapy treatments already being used become more effective.
The process could be tested on patients within two years.
Dr Alan Worsley from Cancer Research UK - which funded the research - says it could be game-changing.
IN: "The main…
OUT: …that way."
DUR: 31 seconds
http://www.fsnradionews.com/feeds/0304cancer-worsley1.mp3
ALT:
Dr Alan Worsley from Cancer Research UK - which funded the research - says it could be game-changing.
IN: "What we…
OUT: …targeting."
DUR: 21 seconds
http://www.fsnradionews.com/feeds/0304cancer-worsley2.mp3
A team from University College says that by analysing patients' DNA, bespoke treatment can be chosen for cancer sufferers, thus steering the immune system to kill off tumours.
Some experts warn the process could be expensive and complicated.
Others say it could help immunotherapy treatments already being used become more effective.
The process could be tested on patients within two years.
Dr Alan Worsley from Cancer Research UK - which funded the research - says it could be game-changing.
IN: "The main…
OUT: …that way."
DUR: 31 seconds
http://www.fsnradionews.com/feeds/0304cancer-worsley1.mp3
ALT:
Dr Alan Worsley from Cancer Research UK - which funded the research - says it could be game-changing.
IN: "What we…
OUT: …targeting."
DUR: 21 seconds
http://www.fsnradionews.com/feeds/0304cancer-worsley2.mp3